The Indian peptides market is projected to reach USD 883.0 Million by 2022 from USD 381.8 Million in 2016, at a CAGR of 15.0%.
Indian Peptides Market: Patent Expiry of Blockbuster Peptides
MarketsandMarkets™ - Dec 16, 2020
Tag:- Indian peptides market
Indian Peptides Market: Patent Expiry of Blockbuster Peptides
MarketsandMarkets™ - Oct 16, 2020
The Indian peptide market is projected to reach USD 883.0 Million by 2022 from USD 381.8 Million in 2016, at a CAGR of 15.0%.
Rising Incidence of Diseases in Indian Peptides Market
MarketsandMarkets™ - Aug 26, 2020
The Indian peptide drugs market is expected to reach USD 883.0 Million in 2022 from USD 381.8 Million in 2016 and is expected to register a CAGR of 15.0%.
Indian Peptides and Heparin Market: An Emerging Market with Attractive Growth Opportunities
MarketsandMarkets™ - Aug 26, 2019
The Indian peptide drugs market is expected to reach USD 883.0 Million in 2022 from USD 381.8 Million in 2016 and is expected to register a CAGR of 15.0%.
The Indian Peptides and Heparin Market worth 883.0 Million and 170.2 Million USD by 2022, respectively
MarketsandMarkets™ - Feb 15, 2018
Increasing prevalence of chronic diseases such as cancer and diabetes and favorable government policies for the pharmaceutical sector are the major factors driving the growth of Indian peptides market.
The Indian Peptides and Heparin Market worth 883.0 Million and 170.2 Million USD by 2022, respectively
MarketsandMarkets™ - Sep 15, 2017
Increasing prevalence of chronic diseases such as cancer and diabetes and favorable government policies for the pharmaceutical sector are the major factors driving the growth of Indian peptides market.
The Indian Peptides and Heparin Market worth 883.0 Million and 170.2 Million USD by 2022, respectively
MarketsandMarkets™ - Aug 31, 2017
The Indian peptides market is projected to reach USD 883.0 Million by 2022 from USD 381.8 Million in 2016, at a CAGR of 15.0%.